1-7 of 7
Authors: Howard Colman
Journal Article
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma Open Access
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae202, https://doi.org/10.1093/noajnl/vdae202
Published: 22 November 2024
Journal Article
D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide Open Access
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae063, https://doi.org/10.1093/noajnl/vdae063
Published: 23 April 2024
Journal Article
Profiling the molecular and clinical landscape of glioblastoma utilizing the Oncology Research Information Exchange Network brain cancer database Open Access
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae046, https://doi.org/10.1093/noajnl/vdae046
Published: 27 March 2024
Journal Article
10007-ACT-2 FIRST IN HUMAN STUDY OF DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN RECURRENT HIGH-GRADE GLIOMA (HGG): PRELIMINARY RESULTS Open Access
Neuro-Oncology Advances, Volume 5, Issue Supplement_5, December 2023, Page v2, https://doi.org/10.1093/noajnl/vdad141.006
Published: 10 December 2023
Journal Article
ACT-13 DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA: A FIRST-IN-HUMAN, PHASE 1 STUDY Open Access
Neuro-Oncology Advances, Volume 4, Issue Supplement_3, December 2022, Pages iii8–iii9, https://doi.org/10.1093/noajnl/vdac167.030
Published: 03 December 2022
Journal Article
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial Open Access
Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdab186, https://doi.org/10.1093/noajnl/vdab186
Published: 24 December 2021
Journal Article
THER-07. DEVELOPMENT OF A NEW MOLECULAR PREDICTOR FOR RISK OF BRAIN METASTASES AND EFFICACY OF TARGETED THERAPY IN MELANOMA Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i12, https://doi.org/10.1093/noajnl/vdz014.050
Published: 12 August 2019
